Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Adverse Effect
Interventions
DRUG

Alpha-Agonist

The maternal systolic blood pressure was consistently maintained above 80% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.

DRUG

α-adrenergic receptor agonist

The maternal systolic blood pressure was consistently maintained above 90% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER

NCT06151444 - Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients | Biotech Hunter | Biotech Hunter